Yeşim Kurtaiş Aytür

Yeşim Kurtaiş Aytür

Auto-generated profile, based on publicly available information

Yeşim Kurtaiş Aytür

Department of Physical Medicine and Rehabilitation, Ankara University Faculty of Medicine, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2011 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
YKYeşim Kurtaiş
Yeşim Kurtaiş
DŐDerya Őztuna
Derya Őztuna
AKAyşe A Küçükdeveci
Ayşe A Küçükdeveci
SKSim Kutlay
Sim Kutlay
MHMeliha Hafiz
Meliha Hafiz
ATAlan Tennant
Alan Tennant
Background: This study aimed to investigate the reliability and construct validity of the International Classification of Functioning, Disability and Health (ICF) Comprehensive Core Set for osteoarthritis (OA) in order to test its possible use as a measuring tool for functioning. Methods: 100 patients with OA (84 F, 16 M; mean age 63 yr) completed forms including demographic and clinical information besides the Short Form (36) Health Survey (SF-36®) and the Western Ontario and McMaster Universities Index of Osteoarthritis (WOMAC). The ICF Comprehensive Core Set for OA was filled by health professionals. The internal construct validities of "Body Functions-Body structures" (BF-BS), "Activity" (A), "Participation" (P) and "Environmental Factors" (EF) domains were tested by Rasch analysis and reliability by internal consistency and person separation index (PSI). External construct validity was evaluated by correlating the Rasch transformed scores with SF-36 and WOMAC. Results: In each scale, some items showing disordered thresholds were rescored, testlets were created to overcome the problem of local dependency and items that did not fit to the Rasch model were deleted. The internal construct validity of the four scales (BF-BS 16 items, A 8 items, P 7 items, EF 13 items) were good [mean item fit (SD) 0.138 (0.921), 0.216 (1.237), 0.759 (0.986) and -0.079 (2.200); person item fit (SD) -0.147 (0.652), -0.241 (0.894), -0.310 (1.187) and -0.491 (1.173) respectively], indicating a single underlying construct for each scale. The scales were free of differential item functioning (DIF) for age, gender, years of education and duration of disease. Reliabilities of the BF-BS, A, P, and EF scales were good with Cronbach's alphas of 0.79, 0.86, 0.88, and 0.83 and PSI's of 0.76, 0.86, 0.87, and 0.71, respectively. Rasch scores of BF-BS, A, and P showed moderate correlations with SF-36 and WOMAC scores where the EF had significant but weak correlations only with SF36-Social Functioning and SF36-Mental Health. Conclusion: Since the four different scales derived from BF-BS, A, P, and EF components of the ICF core set for OA were shown to be valid and reliable through a combination of Rasch analysis and classical psychometric methods, these might be used as clinical assessment tools.

17 May 2018 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
TTTiraje Tuncer
Tiraje Tuncer
FÇFatih Hasan Çay
Fatih Hasan Çay
LALale Altan
Lale Altan
GGGulcan Gurer
Gulcan Gurer
CKCahit Kacar
Cahit Kacar
ZUZeliha Unlu
Zeliha Unlu

25 May 2021 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Open access
YAYeşim Kurtaiş Aytür
Yeşim Kurtaiş Aytür
BKBelma Füsun Köseoglu
Belma Füsun Köseoglu
Ozden Ozyemisci TaskiranOzden Ozyemisci Taskiran
Ozden Ozyemisci Taskiran
NGNilüfer Kutay Ordu Gökkaya
Nilüfer Kutay Ordu Gökkaya
SDSibel Ünsal Delialioğlu
Sibel Ünsal Delialioğlu
CTCanan Tıkız
Canan Tıkız
Coronavirus disease 2019 (COVID-19) is a contagious infection disease, which may cause respiratory, physical, psychological, and generalized systemic dysfunction. The severity of disease ranges from an asymptomatic infection or mild illness to mild or severe pneumonia with respiratory failure and/or death. COVID-19 dramatically affects the pulmonary system. This clinical practice guideline includes pulmonary rehabilitation (PR) recommendations for adult COVID-19 patients and has been developed in the light of the guidelines on the diagnosis and treatment of COVID-19 provided by the World Health Organization and Republic of Turkey, Ministry of Health, recently published scientific literature, and PR recommendations for COVID-19 regarding basic principles of PR. This national guideline provides suggestions regarding the PR methods during the clinical stages of COVID-19 and post-COVID-19 with its possible benefits, contraindications, and disadvantages.

12 June 2025 in International Journal of Telerehabilitation
Verified
Journal Article
Open access
PDF file
AHAnnie J. Hill
Annie J. Hill
KSKirsten Stangenberg-Gliss
Kirsten Stangenberg-Gliss
YAYeşim Kurtais Aytür
Yeşim Kurtais Aytür
PEPamela Enderby
Pamela Enderby
CAClaudine Auger
Claudine Auger
CLCarl Froilan Leochico
Carl Froilan Leochico
The research into and the adoption of telerehabilitation has greatly expanded over the last two decades. With this increasing level of interest in telerehabilitation there is a need for a comprehensive definition. The Telerehabilitation Special Interest Group of the World Federation of Neurorehabilitation is comprised of a diverse group of researchers from over 30 countries and so is well placed to reach a consensus on a definition of telerehabilitation and disseminate this widely. An e-Delphi approach was employed within the special interest group to reach a consensus on the definition. The agreed comprehensive definition of telerehabilitation includes a formal definition, an abbreviated version and a lay version, each with distinct purposes. A description of the scope of telerehabilitation is included, as well as an overview of the various modes of telerehabilitation. It is anticipated that this definition of telerehabilitation may assist researchers, clinicians, advocates and policy makers in a range of purposes.

1 January 2006 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
YKYesim Kurtais
Yesim Kurtais
SKSehim Kutlay
Sehim Kutlay
SESureyya Ergin
Sureyya Ergin
Fibromyalgia syndrome is a nonarticular rheumatic disorder characterised by diffuse musculoskeletal pain, stiffness, fatigue, disturbed sleep and tender points. The pathophysiology is not well understood and treatment remains a challenge. Although pharmacological therapy is still the primary treatment choice, a long-term effective intervention has not been demonstrated yet. Thus, besides pharmacotherapy, other multimodal interventions are often used. Exercise and cognitive-behavioural treatments which exist in the multimodal approach and encompass largely self-managed strategy, are reviewed in this article. Although, there is a great number of exercise studies, the large diversity of outcome measures and measurement instruments that have been used in studies, varying intensity and types of exercises, small sample sizes, high attrition rates, large variability in baseline function, symptom severity and psychosocial status limit to come to a conclusion about the efficacy of exercise in the treatment of fibromyalgia syndrome. There are also inconclusive results about the efficacy of cognitive-behavioural treatment because of limited number of studies with small sample sizes of patients with fibromyalgia syndrome. However, the results of the trials overall demonstrate the beneficial effects of both different types of exercise and cognitive-behavioural treatment, on the other hand, there is still a need for larger, more systematic and randomised controlled trials to evaluate the effectiveness.

25 August 2022 in Turkish Journal of Physical Medicine and Rehabilitation
Verified
Journal Article
Open access
BTBirkan Sonel Tur
Birkan Sonel Tur
BKBelma Füsun Köseoğlu
Belma Füsun Köseoğlu
NGNilüfer Kutay Ordu Gökkaya
Nilüfer Kutay Ordu Gökkaya
YAYeşim Kurtaiş Aytür
Yeşim Kurtaiş Aytür
Ozden Ozyemisci TaskiranOzden Ozyemisci Taskiran
Ozden Ozyemisci Taskiran
SSSerap Tomruk Sütbeyaz
Serap Tomruk Sütbeyaz
Since the beginning of the pandemic, many novel coronavirus disease 2019 (COVID-19) patients have experienced multisystem involvement or become critically ill and treated in intensive care units, and even died. Among these systemic effects, cardiac involvement may have very important consequences for the patient’s prognosis and later life. Patients with COVID-19 may develop cardiac complications such as heart failure, myocarditis, pericarditis, vasculitis, acute coronary syndrome, and cardiac arrhythmias or trigger an accompanying cardiac disease. The ratio of COVID-19 cardiac involvement ranges between 7 and 28% in hospitalized patients with worse outcomes, longer stay in the intensive care unit, and a higher risk of death. Furthermore, deconditioning due to immobility and muscle involvement can be seen in post-COVID-19 patients and significant physical, cognitive and psychosocial impairments may be observed in some cases. Considering that the definition of health is “a state of complete physical, mental and social well-being”, individuals with heart involvement due to COVID-19 should be rehabilitated by evaluating all these aspects of the disease effect. In the light of the rehabilitation perspective and given the increasing number of patients with cardiac manifestations of COVID-19, in this review, we discuss the rehabilitation principles in this group of patients.